Cargando…
The prognostic value of excision repair cross-complementing Group 1 expression in nasopharyngeal cancer patients
BACKGROUND: Overexpression of excision repair cross-complementing Group 1 (ERCC-1) is related to cisplatin resistance and defective repair of radiation damage. The purpose of this study was to evaluate the clinical significance of excision (ERCC-1) expression in nasopharyngeal cancer (NPC). MATERIAL...
Autores principales: | Chitapanarux, Imjai, Lekawanvijit, Suree, Sripan, Patumrat, Mahanupab, Pongsak, Chakrabandhu, Somvilai, Onchan, Wimrak, Sittitrai, Pichit, Boonlert, Donyarat, Klibngern, Hanpon, Samuckkeethum, Wisarut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306241/ https://www.ncbi.nlm.nih.gov/pubmed/32582340 http://dx.doi.org/10.4103/jrms.JRMS_787_18 |
Ejemplares similares
-
Pedicled Flaps versus Free Flaps for Oral Cavity Cancer Reconstruction: A Comparison of Complications, Hospital Costs, and Functional Outcomes
por: Sittitrai, Pichit, et al.
Publicado: (2022) -
Stereotactic radiosurgery for limited brain metastasis using three different techniques: helical tomotherapy, volumetric modulated arc therapy, and cone-based LINAC radiosurgery
por: Jia-Mahasap, Bongkot, et al.
Publicado: (2022) -
Clinical outcomes and dosimetric study of hypofractionated Helical TomoTherapy in breast cancer patients
por: Chitapanarux, Imjai, et al.
Publicado: (2019) -
Brachytherapy dose changes: comparing in-room and out-room image-guided brachytherapy. A randomized study
por: Muangwong, Pooriwat, et al.
Publicado: (2022) -
Ten-Year Outcome of Different Treatment Modalities for Squamous Cell Carcinoma of Oral Cavity
por: Chitapanarux, Imjai, et al.
Publicado: (2017)